ClinVar Genomic variation as it relates to human health
NM_000249.4(MLH1):c.2194_2205delinsG (p.Lys732fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000249.4(MLH1):c.2194_2205delinsG (p.Lys732fs)
Variation ID: 1787455 Accession: VCV001787455.2
- Type and length
-
Indel, 12 bp
- Location
-
Cytogenetic: 3p22.2 3: 37050576-37050587 (GRCh38) [ NCBI UCSC ] 3: 37092067-37092078 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Nov 29, 2022 May 1, 2024 Sep 8, 2022 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000249.4:c.2194_2205delinsG MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000240.1:p.Lys732fs frameshift NM_000249.3:c.2194_2205del12insG frameshift NM_001167617.3:c.1900_1911delinsG NP_001161089.1:p.Lys634fs frameshift NM_001167618.3:c.1471_1482delinsG NP_001161090.1:p.Lys491fs frameshift NM_001167619.3:c.1471_1482delinsG NP_001161091.1:p.Lys491fs frameshift NM_001258271.2:c.1987_1998delinsG NP_001245200.1:p.Lys663fs frameshift NM_001258273.2:c.1471_1482delinsG NP_001245202.1:p.Lys491fs frameshift NM_001258274.3:c.1471_1482delinsG NP_001245203.1:p.Lys491fs frameshift NM_001354615.2:c.1471_1482delinsG NP_001341544.1:p.Lys491fs frameshift NM_001354616.2:c.1471_1482delinsG NP_001341545.1:p.Lys491fs frameshift NM_001354617.2:c.1471_1482delinsG NP_001341546.1:p.Lys491fs frameshift NM_001354618.2:c.1471_1482delinsG NP_001341547.1:p.Lys491fs frameshift NM_001354619.2:c.1471_1482delinsG NP_001341548.1:p.Lys491fs frameshift NM_001354620.2:c.1900_1911delinsG NP_001341549.1:p.Lys634fs frameshift NM_001354621.2:c.1171_1182delinsG NP_001341550.1:p.Lys391fs frameshift NM_001354622.2:c.1171_1182delinsG NP_001341551.1:p.Lys391fs frameshift NM_001354623.2:c.1171_1182delinsG NP_001341552.1:p.Lys391fs frameshift NM_001354624.2:c.1120_1131delinsG NP_001341553.1:p.Lys374fs frameshift NM_001354625.2:c.1120_1131delinsG NP_001341554.1:p.Lys374fs frameshift NM_001354626.2:c.1120_1131delinsG NP_001341555.1:p.Lys374fs frameshift NM_001354627.2:c.1120_1131delinsG NP_001341556.1:p.Lys374fs frameshift NM_001354628.2:c.2101_2112delinsG NP_001341557.1:p.Lys701fs frameshift NM_001354629.2:c.2095_2106delinsG NP_001341558.1:p.Lys699fs frameshift NM_001354630.2:c.2029_2040delinsG NP_001341559.1:p.Lys677fs frameshift NC_000003.12:g.37050576_37050587delinsG NC_000003.11:g.37092067_37092078delinsG NG_007109.2:g.62227_62238delinsG LRG_216:g.62227_62238delinsG LRG_216t1:c.2194_2205delAAACATTTCACAinsG LRG_216p1:p.Lys732Glyfs - Protein change
- K391fs, K663fs, K634fs, K701fs, K732fs, K677fs, K699fs, K374fs, K491fs
- Other names
- -
- Canonical SPDI
- NC_000003.12:37050575:AAACATTTCACA:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MLH1 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
5691 | 5752 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
criteria provided, single submitter
|
Sep 8, 2022 | RCV002420075.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Sep 08, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002724933.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The c.2194_2205del12insG pathogenic mutation, located in coding exon 19 of the MLH1 gene, results from the deletion of 12 nucleotides and insertion of one nucleotide … (more)
The c.2194_2205del12insG pathogenic mutation, located in coding exon 19 of the MLH1 gene, results from the deletion of 12 nucleotides and insertion of one nucleotide causing a translational frameshift with a predicted alternate stop codon (p.K732Gfs*10). This alteration occurs at the 3' terminus of theMLH1 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 25 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This alteration has been identified as somatic in conjunction with MLH1 copy neutral loss of heterozygosity (CN-LOH) in a MSI-H colon tumor with loss of MLH1/PMS2 expression by immunohistochemistry where MLH1 promotor hypermethylation was negative (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated May 01, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.